- Home
- MEC vs TSHA Comparison
MEC vs TSHA Comparison
Compare MEC & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEC
- TSHA
- Stock Information
- Founded
- MEC 1945
- TSHA 2019
- Country
- MEC United States
- TSHA United States
- Employees
- MEC N/A
- TSHA N/A
- Industry
- MEC Industrial Specialties
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- MEC Industrials
- TSHA Health Care
- Exchange
- MEC Nasdaq
- TSHA Nasdaq
- Market Cap
- MEC 324.5M
- TSHA 356.7M
- IPO Year
- MEC 2019
- TSHA 2020
- Fundamental
- Price
- MEC $14.46
- TSHA $1.70
- Analyst Decision
- MEC Strong Buy
- TSHA Strong Buy
- Analyst Count
- MEC 3
- TSHA 8
- Target Price
- MEC $20.67
- TSHA $6.63
- AVG Volume (30 Days)
- MEC 127.3K
- TSHA 1.5M
- Earning Date
- MEC 03-04-2025
- TSHA 05-13-2025
- Dividend Yield
- MEC N/A
- TSHA N/A
- EPS Growth
- MEC 226.32
- TSHA N/A
- EPS
- MEC 1.24
- TSHA N/A
- Revenue
- MEC $581,604,000.00
- TSHA $8,333,000.00
- Revenue This Year
- MEC $4.91
- TSHA N/A
- Revenue Next Year
- MEC $1.59
- TSHA N/A
- P/E Ratio
- MEC $11.55
- TSHA N/A
- Revenue Growth
- MEC N/A
- TSHA N/A
- 52 Week Low
- MEC $12.75
- TSHA $1.19
- 52 Week High
- MEC $23.02
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- MEC 43.88
- TSHA 49.82
- Support Level
- MEC $14.00
- TSHA $1.69
- Resistance Level
- MEC $14.47
- TSHA $1.82
- Average True Range (ATR)
- MEC 0.70
- TSHA 0.10
- MACD
- MEC 0.04
- TSHA 0.01
- Stochastic Oscillator
- MEC 61.47
- TSHA 43.33
About MEC Mayville Engineering Company Inc.
Mayville Engineering Co Inc is involved in a manufacturing partner that provides a broad range of prototyping and tooling, production fabrication, coating, assembly, and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.